DNA AMPLIFICATION FROM MICRODISSECTED CHROMOSOMES

Information

  • Research Project
  • 3499150
  • ApplicationId
    3499150
  • Core Project Number
    R43GM050658
  • Full Project Number
    1R43GM050658-01
  • Serial Number
    50658
  • FOA Number
  • Sub Project Id
  • Project Start Date
    12/1/1993 - 32 years ago
  • Project End Date
    5/31/1994 - 32 years ago
  • Program Officer Name
  • Budget Start Date
    12/1/1993 - 32 years ago
  • Budget End Date
    5/31/1994 - 32 years ago
  • Fiscal Year
    1994
  • Support Year
    1
  • Suffix
  • Award Notice Date
    11/11/1993 - 32 years ago

DNA AMPLIFICATION FROM MICRODISSECTED CHROMOSOMES

In this project we will develop kits, services, and reagents useful in the processes of generating and employing amplified DNA mini-libraries (i.e., amplified products) from microdissected human chromosome fragments. The focus of Phase I studies will be development of standard protocols for generating such mini-libraries. Two amplification strategies are proposed based on their use of recognition sites distributed throughout the human genome at about 250 bp intervals (insuring representative coverage of genomic sequences in the min- library). The strategies are based on DNA sequence recognition by Mbo I cleavage and by oligonucleotide hybridization to the most common 6 bp sequences in the human genome. DNA products obtained from both strategies are PCR amplified with a single adaptor oligonucleotide. The products of the amplification reactions will be analyzed for the amount and size of DNA, degree of genome coverage, hybridization specificity, retrievability upon reamplification, ease of use and reproducibility. Based on amplification strategies developed in Phase I, we will ultimately make available to the human genom research community standardized reagents that can be used: a) for obtaining region-specific clones (i.e., genomic clones for contig assembly/map closure, and/or cDNA clones to identify novel genes), b) as starting material for isolation of region-specific STSs, and c) as hybridization/amplification targets for subchromosome localization.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    821
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG7
  • Study Section Name
  • Organization Name
    GENAISSANCE PHARMACEUTICALS, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    NEW HAVEN
  • Organization State
    CT
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    06511
  • Organization District
    UNITED STATES